Internationalisation

At Medtech4Health, we strive to work through increased collaboration between a number of organizations for increased exchange between Swedish medical technology and players in other countries. The focus is on the projects and companies that have received funding from Medtech4Health. Here we collect information that can contribute to the internationalization work for your project or company, such as which partners Medtech4Health works with and current seminars and announcements.

Background

Small and medium-sized innovative medical companies often experience demands for internationalisation at an early stage. This is a central and difficult challenge, as small and medium-sized medical technology enterprises (SMEs) are rarely equipped for this task. A study Medtech4Health produced in 2019 showed that:

• internationalisation is one of the foremost strategic challenges for a company,
• effective internationalisation lays invaluable foundations for later added value,
• it is difficult to find partners to collaborate with, for studies and for support regarding regulatory conditions, compensation systems, distribution, procurement, etc.,
• it is costly and time consuming to make mistakes and it may take a long time before one realises one is on the wrong path or working with the wrong partner,
• there are good examples of functioning support mechanisms in different parts of the country, while there are also many gaps.

Effect

Through strategically selected collaboration, good operations are strengthened and new ones created. Such collaboration generates:

• increased qualified contact areas for Swedish innovative medtech SMEs,
• increased qualified partnerships (studies, distribution, development, investments),
• increased visibility and contacts for Swedish companies as regards European and Swedish investors with experience in Medtech related areas,
• increased visibility and contacts for Swedish researchers as regards the European research élite in medical technology,
• increased visibility and influence for medical technology as an area within EU calls for funding applications, and with the Swedish Research Council and other financiers.